BrightPath Biotherapeutics Co., Ltd. Price (4594.T)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

64,162,271

(7.5461)%

Income Statement Summary

Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Operating Income
Other Expenses
Net Income
news-img
BrightPath Biotherapeutics Co., Ltd.
news-img

Income Statement

BrightPath Biotherapeutics Co., Ltd.

Currency: JPY

YEAR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Revenue
Revenue 821,625,000.00

+0%

822,556,000.00

+0%

529,612,000.00

-36%

354,410,000.00

-33%

155,808,000.00

-56%

11,300,000.00

-93%

2,504,000.00

-78%

15,408,000.00

+515%

5,280,000.00

-66%

72,000.00

-99%

Cost of Revenue
Cost of Revenue 766,619,000.00 771,657,000.00 524,913,000.00 315,174,000.00 70,702,000.00 4,467,000.00 1,145,000.00 3,317,000.00 1,895,000.00 413,000.00
Gross Profit
Gross Profit 55,006,000.00

+0%

50,899,000.00

-7%

4,699,000.00

-91%

39,236,000.00

+735%

85,106,000.00

+117%

6,833,000.00

-92%

1,359,000.00

-80%

12,091,000.00

+790%

3,385,000.00

-72%

-341,000.00

-110%

Gross Profit Ratio (0.07%) (0.06%) (0.01%) (0.11%) (0.55%) (0.60%) (0.54%) (0.79%) (0.64%) (-4.74%)
Operating Expenses
Research and Development 0.00 848,993,000.00 816,783,000.00 1,146,584,000.00 1,387,674,000.00 1,484,854,000.00 1,408,443,000.00 1,135,847,000.00 1,168,473,000.00 775,556,000.00
General and Administrative 0.00 0.00 67,000,000.00 74,000,000.00 0.00 0.00 0.00 0.00 0.00 0.00
Selling, General & Admin... 0.00 190,563,000.00 298,195,000.00 493,804,000.00 308,825,000.00 286,857,000.00 259,029,999.00 317,154,000.00 285,251,000.00 379,182,000.00
Selling & Marketing Exp... 0.00 0.00 231,195,000.00 419,804,000.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation and Amortiz... 8,802,000.00 19,304,000.00 42,707,000.00 73,210,000.00 82,770,000.00 62,471,000.00 66,688,000.00 35,123,000.00 16,719,000.00 395,000.00
Other Expenses 86,092,000.00 13,955,000.00 12,562,000.00 -81,000.00 -10,265,000.00 301,000.00 98,000.00 89,000.00 241,000.00 0.00
Total Operating Expenses 547,192,000.00 1,039,649,000.00 1,118,249,000.00 1,600,968,000.00 1,750,655,000.00 1,834,182,000.00 1,734,161,000.00 1,488,124,000.00 1,470,443,000.00 1,154,738,000.00
Cost and Exponses 1,313,811,000.00 1,811,306,000.00 1,643,162,000.00 1,916,142,000.00 1,821,357,000.00 1,838,649,000.00 1,735,306,000.00 1,491,441,000.00 1,472,338,000.00 1,155,151,000.00
Operating Income
Operating Income -492,186,000.00

+0%

-988,750,000.00

+101%

-1,113,550,000.00

+13%

-1,561,732,000.00

+40%

-1,665,548,000.00

+7%

-1,827,349,000.00

+10%

-1,732,802,000.00

-5%

-1,476,033,000.00

-15%

-1,467,059,000.00

-1%

-1,155,079,000.00

-21%

Operating Income Ratio (-0.60%) (-1.20%) (-2.10%) (-4.41%) (-10.69%) (-161.71%) (-692.01%) (-95.80%) (-277.85%) (-16,042.76%)
Other Income and Exp...
Interest Income 129,000.00 274,000.00 33,000.00 46,000.00 1,762,000.00 42,000.00 35,000.00 27,000.00 20,000.00 12,000.00
Interest Expenses 6,493,000.00 16,000.00 13,647,000.00 0.00 0.00 0.00 9,099,000.00 362,000.00 61,000.00 1,399,000.00
Total Other Income/Exp... 83,754,000.00 -4,227,000.00 -3,378,000.00 -10,198,000.00 -214,981,000.00 -32,512,000.00 15,588,000.00 -5,739,000.00 -16,674,000.00 -11,103,000.00
EBITDA
EBITDA -399,630,000.00 -973,673,000.00 -1,070,843,000.00 -1,488,523,000.00 -1,582,779,000.00 -1,764,879,000.00 -1,650,527,000.00 -1,446,287,000.00 -1,466,952,000.00 -1,165,786,000.00
EBITDA ratio (-0.49%) (-1.18%) (-2.02%) (-4.20%) (-8.86%) (-153.01%) (-673.94%) (-93.88%) (-275.95%) (-16,191.47%)
Income Before Tax
Income Before Tax -408,432,000.00 -992,977,000.00 -1,116,928,000.00 -1,573,292,000.00 -1,880,529,000.00 -1,859,861,000.00 -1,717,214,000.00 -1,481,772,000.00 -1,483,733,000.00 -1,166,182,000.00
Income Before Tax Ratio (-0.50%) (-1.21%) (-2.11%) (-4.44%) (-12.07%) (-164.59%) (-685.79%) (-96.17%) (-281.01%) (-16,196.97%)
Income Tax Expense
Income Tax Expense 4,003,000.00 1,487,000.00 5,071,000.00 5,124,000.00 3,788,000.00 -2,087,000.00 2,420,000.00 2,420,000.00 1,900,000.00 1,900,000.00
Net Income
Net Income -412,435,000.00

+0%

-994,464,000.00

+141%

-1,113,661,000.00

+12%

-1,577,142,000.00

+42%

-1,884,318,000.00

+19%

-1,857,774,000.00

-1%

-1,719,634,000.00

-7%

-1,484,192,000.00

-14%

-1,485,633,000.00

+0%

-1,168,082,000.00

-21%

Net Income Ratio (-0.50%) (-1.21%) (-2.10%) (-4.45%) (-12.09%) (-164.40%) (-686.75%) (-96.33%) (-281.37%) (-16,223.36%)
Earning Per Share
Basic EPS -20.34 -35.28 -32.74 -41.25 -44.95 -44.20 -36.14 -28.55 -24.90 -18.21
Diluted EPS -20.34 -35.28 -32.74 -41.25 -44.95 -44.20 -36.14 -28.55 -24.90 -18.21
Share Outstanding
Basic Share Outstanding 20,274,100.00 28,184,750.00 34,014,937.00 38,233,745.00 41,916,427.00 42,031,977.00 47,581,918.00 51,993,131.00 59,660,271.00 64,162,271.00
Diluted Share Outstanding 20,274,100.00 28,184,750.00 34,014,937.00 38,233,745.00 41,916,427.00 42,031,977.00 47,581,918.00 51,993,131.00 59,660,271.00 64,162,271.00
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation